Draft genome sequence of <i>Catenibacterium mistuoki</i> isolated from the fecal sample of a melanoma patient with complete response to immunotherapy
A strain of <i>Catenibacterium</i> spp. was isolated from a fecal sample of a patient diagnosed with stage IV melanoma in December 2008. The patient began treatment with the immune checkpoint inhibitor pembrolizumab in May 2016 and has since exhibited a sustained complete response to the therapy.
Authors
- Nora Berois (ORCID: https://orcid.org/0000-0002-6372-2540)
- Francisco F. Peñalba
- Andrés Parada (ORCID: https://orcid.org/0000-0003-0100-7100)
- Nabila Elgul
- Nadia Riera (ORCID: https://orcid.org/0000-0001-6295-6452)
- Gregorio Iraola (ORCID: https://orcid.org/0000-0002-6516-3404)
- Eduardo Osinaga (ORCID: https://orcid.org/0000-0003-2283-7066)
- María Isabel Alonso
Institutions
- Wellcome Sanger Institute (GB)
- Center for Innovation (US)
- Institut Pasteur de Montevideo (UY)
- Centro Uruguayo de Imagenología Molecular (UY)
Publication Details
- Journal
- Microbiology Resource Announcements
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1128/mra.00732-25
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00